The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, HBM Holdings's share price is $0.482.
HBM Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.12. Hence, HBM Holdings's PS Ratio for today is 4.05.
The historical rank and industry rank for HBM Holdings's PS Ratio or its related term are showing as below:
HBMHF'
s PS Ratio Range Over the Past 10 Years
Min: 1.11 Med: 14.1 Max: 194.55
Current: 1.55
During the past 6 years, HBM Holdings's highest PS Ratio was 194.55. The lowest was 1.11. And the median was 14.10.
HBMHF's PS Ratio is ranked better than 88.68% of 998
companies
in the Biotechnology industry
Industry Median: 9.14
vs HBMHF: 1.55
During the past 12 months, the average Revenue per Share Growth Rate of HBM Holdings was 116.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 14.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 100.20% per year.
During the past 6 years, HBM Holdings's highest 3-Year average Revenue per Share Growth Rate was 99.10% per year. The lowest was 14.80% per year. And the median was 45.30% per year.
Back to Basics: PS Ratio
HBM Holdings PS Ratio Historical Data
The historical data trend for HBM Holdings's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, HBM Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HBM Holdings's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, HBM Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where HBM Holdings's PS Ratio falls into.
HBM Holdings PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
HBM Holdings's PS Ratio for today is calculated as
HBM Holdings's Share Price of today is $0.482.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HBM Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
HBM Holdings PS Ratio Related Terms
Thank you for viewing the detailed overview of HBM Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. Majority of revenue is generated from Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HBMHF has been successfully added to your 